Cellectis Reports Financial Results for the Second Quarter 2026
Lasme-cel: Pivotal Phase 2 in r/r B-ALL (BALLI-01)
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.